$Bluejay Diagnostics(BJDX.US)$ IMMEDIATE RELEASE Date: December 27, 2023 Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) This Study performs unique rapid on-site measurements of interleukin-6 (IL-6) and positions Company to move forward with multiple initiatives. ACTON, Mass., Dec 27, 2023 – Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company...
$Bluejay Diagnostics(BJDX.US)$Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) 2 MINUTES AGO, 9:00 AM EST VIA GLOBENEWSWIRE
$Bluejay Diagnostics(BJDX.US)$This is how the hedgies help us lose our money. I’m pretty sure they have more powerful systems than the pentagon. They are the scum of this earth and this bullshit must stop. They’re effing with people like my parents retirement accounts. Nobody should be allowed to manipulate any stock!$AMC院線(AMC.US)$
$Bluejay Diagnostics(BJDX.US)$reported quarterly losses of $(2.08) per share. This is a 30.67 percent increase over losses of $(3.00) per share from the same period last year.
Bluejay Diagnostics股票討論區
A bit more to add! Very interesting, I think?
IMMEDIATE RELEASE
Date: December 27, 2023
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating
Symphony IL-6 in Sepsis Patients (SYMON Study)
This Study performs unique rapid on-site measurements of interleukin-6 (IL-6) and positions Company to move forward with multiple initiatives.
ACTON, Mass., Dec 27, 2023 – Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company...
Update
2 MINUTES AGO, 9:00 AM EST
VIA GLOBENEWSWIRE
Slowly gap up from bottoms
800k float at 3.3
why no go up?
暫無評論